Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic and Addiction Indices in Patients on Opioid Agonist Medication-Assisted Treatment: A Comparison of Buprenorphine and Methadone
Igor Elman, Margaret Howard, Jacob T. Borodovsky, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Validity of mental and physical stress models
Erin Hendry, Brady McCallister, Dan J. Elman, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 158, pp. 105566-105566
Closed Access | Times Cited: 5
High BMI is a specific risk factor for drug‐related mortality in patients receiving methadone: A case control study
Thikra Algahtani, Tom Le Ruez, John Strang, et al.
Addiction (2025)
Open Access
Treatments for weight gain in schizophrenia
Igor Elman
Current Opinion in Psychiatry (2025)
Closed Access
Endogenous opiates and behavior: 2020
Richard J. Bodnar
Peptides (2022) Vol. 151, pp. 170752-170752
Closed Access | Times Cited: 19
Insulin in the ventral tegmental area reduces cocaine‐evoked dopamine in the nucleus accumbens in vivo
Lindsay Naef, Lauren T. Seabrook, Jeff Hsiao, et al.
European Journal of Neuroscience (2018) Vol. 50, Iss. 3, pp. 2146-2155
Open Access | Times Cited: 37
A Novel Precision Approach to Overcome the “Addiction Pandemic” by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration
Kenneth Blum, Shan Kazmi, Edward J. Modestino, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 3, pp. 212-212
Open Access | Times Cited: 24
Contextual processing and its alterations in patients with addictive disorders
Igor Elman, Dan Ariely, Marina Tsoy-Podosenin, et al.
Addiction Neuroscience (2023) Vol. 7, pp. 100100-100100
Open Access | Times Cited: 9
Effects of a Two-Month Exercise Training Program on Concurrent Non-Opiate Substance Use in Opioid-Dependent Patients during Substitution Treatment
Alexandros Psarianos, Costas Chryssanthopοulos, Athanasios G. Theocharis, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 941-941
Open Access | Times Cited: 3
Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?
Marjorie C. Gondré‐Lewis, Igor Elman, Tanya N. Alim, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 870-870
Open Access | Times Cited: 15
The Effects of Probiotic Supplementation on Opioid-Related Disorder in Patients under Methadone Maintenance Treatment Programs
Nader Molavi, Morad Rasouli‐Azad, Hamed Mirzaei, et al.
International Journal of Clinical Practice (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 13
The omnipresence of autonomic modulation in health and disease
Julia Forstenpointner, Igor Elman, Roy Freeman, et al.
Progress in Neurobiology (2022) Vol. 210, pp. 102218-102218
Open Access | Times Cited: 9
Sex differences in weight gain during medication-based treatment for opioid use disorder: A meta-analysis and retrospective analysis of clinical trial data
Peter Manza, Danielle S. Kroll, Katherine McPherson, et al.
Drug and Alcohol Dependence (2022) Vol. 238, pp. 109575-109575
Open Access | Times Cited: 9
Ketogenic diet enhances the effects of oxycodone in mice
Richard Trinko, Daniella Diaz, Ethan Foscue, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Weight change among patients engaged in medication treatment for opioid use disorder: a scoping review
Meagan M. Carr, Raissa Lou, Grace Macdonald-Gagnon, et al.
The American Journal of Drug and Alcohol Abuse (2023) Vol. 49, Iss. 5, pp. 551-565
Open Access | Times Cited: 5
Functional genetics reveals the contribution of delta opioid receptor to type 2 diabetes and beta-cell function
Sarah Meulebrouck, Judith Merrheim, Gurvan Quéniat, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial
Christina McAnulty, Gabriel Bastien, M. Eugenia Socías, et al.
Drug and Alcohol Dependence (2022) Vol. 239, pp. 109604-109604
Open Access | Times Cited: 7
Regulation of body weight and food intake by AGRP neurons during opioid dependence and abstinence in mice
Brenton T. Laing, Aishwarya Jayan, Lydia J. Erbaugh, et al.
Frontiers in Neural Circuits (2022) Vol. 16
Open Access | Times Cited: 7
“Preaddiction” construct and reward deficiency syndrome: genetic link via dopaminergic dysregulation
Kenneth Blum, Igor Elman, Catherine A. Dennen, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 21, pp. 1181-1181
Open Access | Times Cited: 7
A neuroimaging investigation into the role of peripheral metabolic biomarkers in the anticipation of reward in alcohol use
Monica L. Faulkner, Reza Momenan, Lorenzo Leggio
Drug and Alcohol Dependence (2021) Vol. 221, pp. 108638-108638
Open Access | Times Cited: 9
Association between body mass index and treatment completion in extended-release naltrexone-treated patients with opioid dependence
Xinyi Li, Daniel D. Langleben, Kevin G. Lynch, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 3
Multicenter Observational/Exploratory Study Addressed to the Evaluation of the Effectiveness and Safety of Pharmacological Therapy in Opioid-Dependent Patients in Maintenance Therapy in Southern Italy
Fatima Maqoud, Giada Fabio, Nunzio Ciliero, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 461-461
Open Access | Times Cited: 5
Folate Status as a Nutritional Indicator among People with Substance Use Disorder; A Prospective Cohort Study in Norway
Mitra Bemanian, Jørn Henrik Vold, Ranadip Chowdhury, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 9, pp. 5754-5754
Open Access | Times Cited: 5
Metabolic Profiles Associated with Opioid Use and Opioid Use Disorder: a Narrative Review of the Literature
Juliana I. Byanyima, Xinyi Li, Sianneh A. Vesslee, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 3, pp. 581-593
Open Access | Times Cited: 2
Blood pressure response to extended-release naltrexone in heroin and prescription opioid users and its implications for cardiovascular morbidity
Zhenhao Shi, Daniel D. Langleben, David Rott, et al.
Journal of Addictive Diseases (2024) Vol. 43, Iss. 1, pp. 77-87
Closed Access
Detection of serum alterations in polysubstance use patients by FT-Raman spectroscopy
Başak Ünübol, Devrim Sarıbal, Zeynep Ceylan, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2024) Vol. 326, pp. 125234-125234
Closed Access
Page 1 - Next Page

Scroll to top